LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 41 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,647,886 | +127.9% | 1,176,680 | +80.6% | 0.01% | +175.0% |
| Q2 2023 | $2,039,758 | -30.9% | 651,680 | 0.0% | 0.00% | -42.9% |
| Q1 2023 | $2,952,110 | +9.7% | 651,680 | 0.0% | 0.01% | +16.7% |
| Q4 2022 | $2,691,438 | +29.1% | 651,680 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $2,085,000 | +502.6% | 651,680 | +268.8% | 0.01% | +400.0% |
| Q2 2022 | $346,000 | -51.7% | 176,680 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $716,000 | -62.4% | 176,680 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $1,906,000 | -6.4% | 176,680 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $2,037,000 | +170.5% | 176,680 | +130.4% | 0.00% | +300.0% |
| Q2 2021 | $753,000 | – | 76,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |